Neuronetics NeuroStar Advanced Therapy System

Investor Relations

Neuronetics, Inc. believes that mental health is as important as physical health. We take a patient-centric approach to designing, developing, and marketing products that improve the quality of life for people who suffer from psychiatric disorders.

NeuroStar® Advanced Therapy for Mental Health is the leading transcranial magnetic stimulation (TMS) treatment for major depressive disorder. With over 4.8 million treatment sessions delivered, it has transformed thousands of lives. NeuroStar is FDA cleared and backed by the world’s largest depression outcomes registry and the largest clinical data set in major depression of any TMS system.

We are committed to the mission of renewing lives by transforming neurohealth.

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Chart